Publication:
Aggressive pituitary tumours and carcinomas: Two sides of the same coin?

dc.contributor.authorTrouillas, Jacqueline (7005876343)
dc.contributor.authorBurman, Pia (7004519451)
dc.contributor.authorMcCormack, Ann (13805484100)
dc.contributor.authorPetersenn, Stephan (6604085672)
dc.contributor.authorPopovic, Vera (57294508600)
dc.contributor.authorDekkers, Olaf (12792905600)
dc.contributor.authorRaverot, Gerald (57215374585)
dc.date.accessioned2025-07-02T12:13:36Z
dc.date.available2025-07-02T12:13:36Z
dc.date.issued2018
dc.description.abstractThe European Society of Endocrinology (ESE) survey reported on the largest cohort of 125 aggressive pituitary tumours (APT) and 40 pituitary carcinomas (PC). Whilst the survey focused on treatment effectiveness, all pathological data were not explored in detail. Here, we comment on some interesting pathological findings, notably the difference between APT and PC. © 2018 European Society of Endocrinology Printed in Great Britain.
dc.identifier.urihttps://doi.org/10.1530/EJE-18-0250
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85046571455&doi=10.1530%2fEJE-18-0250&partnerID=40&md5=39adab5be79c65bf67b45185e1263e40
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/12893
dc.titleAggressive pituitary tumours and carcinomas: Two sides of the same coin?
dspace.entity.typePublication

Files